Related Experiment Video
Updated: Oct 22, 2025

A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro
Published on: June 2, 2022
Low Muscle Mass in Patients Receiving Hemodialysis: Correlations with Vascular Calcification and Vascular Access
Seok-Hyung Kim1, Gwangho Choi1, Youngjin Song1
1Department of Internal Medicine, Chuncheon Sacred Heart Hospital, Chuncheon 24253, Korea.
Insights
Low muscle mass (LMM) is linked to increased vascular calcification (VC) and vascular access failure in hemodialysis patients. Quantifying LMM may help predict access failure, highlighting a new risk factor in chronic kidney disease management.
Area of Science:
- Nephrology
- Geriatrics
- Radiology
Background:
- Sarcopenia, an age-related decline in muscle mass and strength, is a growing concern.
- Vascular calcification (VC) is prevalent in chronic kidney disease (CKD) patients and linked to cardiovascular disease.
- The relationship between low muscle mass (LMM) and vascular access failure in CKD patients requires further investigation.
Purpose of the Study:
- To investigate the correlation between quantified vascular calcification score (VCS) in arm vascular access and LMM.
- To determine if LMM is associated with the incidence of vascular access failure in hemodialysis patients.
Main Methods:
- Vascular calcification score (VCS) was measured using computed tomography (CT) and the Agatston method.
- Low muscle mass (LMM) was defined as skeletal muscle mass below the median, assessed by bioelectrical impedance.
- Logistic regression analyses were used to explore the relationship between LMM and VC, and vascular access failure.
Main Results:
- Low muscle mass (LMM) was independently associated with increased vascular calcification (VC) (HR, 10.415; p = 0.002).
- Patients with LMM had a significantly higher risk of vascular access failure (HR, 3.652; p = 0.03).
- Vascular calcification (VC) fully mediated the relationship between LMM and recurrent vascular access failure.
Conclusions:
- Low muscle mass (LMM), quantified by bioimpedance analysis, is associated with vascular access failure in hemodialysis patients.
- LMM increases the risk of vascular calcification (VC).
- LMM has potential as a predictor of vascular access failure in CKD patients.
Abstract:
Background: Sarcopenia involves an age-related decline in skeletal muscle mass with functional disability or low muscle strength. Vascular calcification (VC) occurs commonly in patients with chronic kidney disease, in whom it is associated with cardiovascular disease. We aimed to investigate the correlations of low muscle mass with the quantified vascular calcification score (VCS) of the arm of vascular access, as well as whether low muscle mass is associated with the incidence of vascular access failure. Methods: The VCS was measured on non-contrast, arm computed tomography using the Agatston method. The lower muscle mass (LMM) group comprised subjects whose skeletal muscle mass of the lower extremities, as measured using bioelectrical impedance, was lower than the median. Higher VC was defined as a score of 500 or above, corresponding to the highest 40% of VCS. The relationship between LMM and VC was explored using univariate and multivariate logistic regression analyses. Results: Seventy-five patients were included, of whom forty-two (56.0%) were men. The median age was 64 years (interquartile range 58-72 years). Of the 75 patients, 73 satisfied the diagnostic criteria for sarcopenia. The median hemodialysis vintage was 49.4 months (range 32.1-99.2 months). No significant differences were found between the non-LMM and LMM groups in sex, end-stage renal disease etiology, and type of vascular access, although the LMM group showed significantly older age and hemodialysis vintage. LMM presented a significant association with VC (hazard ratio (HR) 3.562; 95% CI, 1.341-9.463; p = 0.011). Upon adjustment for hemodialysis vintage, diabetes, and systolic blood pressure, LMM demonstrated an independent association with VC (HR, 10.415; 95% CI, 2.357-46.024; p = 0.002). The risk of vascular access failure was higher in the LMM group (HR, 3.652; 95%, CI 1.135-11.749; p = 0.03). VC was a full mediator in the relationship of LMM with recurrent vascular access failure. Conclusions: We quantified LMM via bioimpedance analysis and found a heretofore-unreported association between LMM and vascular access failure. LMM increases the risk of VC and has the potential to predict vascular access failure.
Related Concept Videos
Hemodialysis II: Procedure and Complications
Hemodialysis III: Nursing Management
Hemodialysis I: Introduction
Chronic Kidney Disease II: Clinical Manifestations
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

